PMID: 9159603Apr 1, 1997Paper

The problem of compliance to cholesterol altering therapy

Journal of Internal Medicine
W Insull

Abstract

This review's purpose is to describe for the practicing clinician the current knowledge about patient compliance to cholesterol-altering drugs and about procedures for compliance management applicable to clinical practice in the United States. Compliance is defined for four commonly measured major steps and, based on recent electronic monitoring data, for three quantitative categories of active medication-taking. The concepts and definition of compliance are undergoing evolutionary changes due to the measurement and availability of new dimensions through electronic monitoring of patient compliance. Substantial non-compliance to cholesterol-altering drugs has been reported in nine large clinical trials for primary and secondary prevention of coronary heart disease, in two HMOs, and, using electronic monitoring of compliance, in one clinical trial and a selected practice. The risks of treatment discontinuation increased continuously during treatment and totaled from 6 to 30% after 5 years. Patterns of day-to-day partial compliance are emerging. Procedures and knowledge for clinical management of compliance are described including methods of measuring compliance, risk factors for non-compliance, standards for compliance performanc...Continue Reading

Citations

Jul 16, 2005·Advances in Therapy·Michelle A HuserVal Berger
Jan 11, 2007·European Journal of Clinical Pharmacology·Annika BardelKurt Svärdsudd
Mar 17, 2005·Cardiovascular Drugs and Therapy·Victoria SeniorUNKNOWN Genetic Risk Assessment for FH Trial (GRAFT) Study Group
Feb 18, 2005·Cardiovascular Drugs and Therapy·Mehmet Birhan YilmazSule Korkmaz
Jan 26, 2006·Cardiovascular Drugs and Therapy·Mehmet Birhan YilmazErsoy Isik
Dec 22, 2005·American Heart Journal·Sonali P KulkarniEric D Peterson
Jul 12, 2011·The Journal of Cardiovascular Nursing·Kimberli Taylor-ClarkeUchechukwu K A Sampson
Nov 16, 2006·Journal of General Internal Medicine·Julie A GazmararianKimberly Rask
Apr 10, 1999·Journal of Clinical Pharmacology·A SchwedR Darioli
Oct 31, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Andreas ZellerPeter Tschudi
Dec 23, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Andreas ZellerEdouard Battegay
Sep 29, 2011·Patient Preference and Adherence·J Travis GosseyRobert J Volk
Feb 24, 2007·Vascular Health and Risk Management·James M BackesPatricia A Howard
May 30, 2009·Vascular Health and Risk Management·Madhuri Devabhaktuni, Sripal Bangalore
Jan 20, 2004·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Chris McCabe
May 5, 2012·Journal of the American Medical Informatics Association : JAMIA·Jeffrey L SchnipperBlackford Middleton
Feb 22, 2012·Medicare & Medicaid Research Review·Steven A BlackwellGerald F Riley
Oct 13, 2009·Expert Review of Pharmacoeconomics & Outcomes Research·Roberta AraAbdullah Pandor
Jul 11, 2009·Journal of the American Pharmacists Association : JAPhA·Yifei LiuWilliam R Doucette
Nov 7, 2007·The Canadian Journal of Cardiology·Steven M EdworthyIsrael Belenkie
Oct 13, 2010·Cardiology Clinics·Uchechukwu K A Sampson, George A Mensah
Feb 27, 2009·Clinical Therapeutics·Sachin Kamal-BahlBaishali M Ambegaonkar
Apr 17, 2007·Patient Education and Counseling·Per Lytsy, Ragnar Westerling
Mar 9, 2007·Patient Education and Counseling·Sunil KripalaniTerry A Jacobson
Oct 7, 2005·Pharmacotherapy·David F BlackburnThomas W Wilson
Jul 9, 2009·Journal of Clinical Pharmacy and Therapeutics·V W Y LeeA C Y Chau
Jul 23, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·L A DonnellyP T Donnan
Dec 17, 2008·Journal of Clinical Nursing·Melinda J CarringtonSimon Stewart
Jun 22, 2011·Health Services Research·Virginia WangMatthew L Maciejewski
Jan 3, 2013·Health Services Research·Pinar Karaca-MandicRobert L Kane
Jun 30, 2012·PLoS Neglected Tropical Diseases·Emily W GowerShannath L Merbs
Aug 26, 2016·Health Services Research·Ibrahim AbbassAjit Appari
Dec 5, 2002·Pharmacoepidemiology and Drug Safety·Young Sik KimUNKNOWN Korea Post-Marketing Surveillance Research Group

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Family Medicine
J H LaRosa, J C LaRosa
Nanomedicine : Nanotechnology, Biology, and Medicine
Mustafa O CağlayanErhan Pişkin
European Journal of Cardiovascular Nursing : Journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology
Elizabeth P TolmieAllan Gaw
© 2021 Meta ULC. All rights reserved